A novel HPLC-RIA method for the simultaneous detection of estrone, estradiol and estrone sulphate levels in breast cancer tissue

Journal of Steroid Biochemistry and Molecular Biology

Volumn 72, Issue 5, 2000, Pages 259-264

  Geisler, Jürgen ^a   Berntsen, Hildegunn ^a   Lønning, Per Eystein ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL DERIVATIVE; ESTRONE; ESTRONE SULFATE; ETHER; IODINE 125; LIGAND; SULFATASE; TRITIUM;

ANALYTIC METHOD; ARTICLE; BREAST BIOPSY; BREAST CANCER; CONTROLLED STUDY; EXTRACTION; FEMALE; FRACTIONATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROLYSIS; MASTECTOMY; PURIFICATION; RADIOIMMUNOASSAY; SAMPLE; TISSUE LEVEL;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL; ESTRONE; FEMALE; HUMANS; NITRILES; POSTMENOPAUSE; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRIAZOLES;

EID: 0034177586     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00036-4     Document Type: Article

References (34)

1. Thomas D.B. Do hormones cause cancer. Cancer. 53:1984;595-604.
2. Lipton A., Santner S.J., Santen R.J., Harvey H.A., Feil P.D., White-Hershey D., Bartholomew M.J., Antle C.E. Aromatase activity in primary and metastatic human breast cancer. Cancer. 59:1987;779-783.
3. Santen R.J., Santner S.J., Pauley R.J., Tait L., Kaseta J., Demers L.M., Hamilton C., Yue W., Wang J.P. Estrogen production via the aromatase enzyme in breast carcinoma: which cell type is responsible? Journal of Steroid Biochemistry and Molecular Biology. 61:1997;267-271.
4. Miller W.R., Mullen P., Telford J., Dixon J.M. Clinical importance of intratumoural aromatase. Breast Cancer Research and Treatment. 49:1998;S27-S32.
5. Reed M.J., Topping L., Coldham N.G., Purohit A., Ghilchik M.W., James V.H.T. Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. Journal of Steroid Biochemistry and Molecular Biology. 44:1993;589-596.
6. Purohit A., Ghilchik M.W., Duncan L., Wang D.Y., Singh A., Walker M.M., Reed M.J. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. Journal of Clinical Endocrinology and Metabolism. 80:1995;3052-3058.
7. Masamura S., Santner S.J., Gimotty P., George J., Santen R.J. Mechanism of maintenance of high breast tumour estradiol concentrations in the absence of ovarian function: role of very high affinity tissue uptake. Breast Cancer Research and Treatment. 42:1997;215-226.
8. Geisler J., King N., Dowsett M., Ottestad L., Lundgren S., Walton P., Kormeset P.O., Lønning P.E. Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer. British Journal of Cancer. 74:1996;1286-1291.
9. Dowsett M., Jones A., Johnston S.R.D., Jacobs S., Trunet P., Smith I.E. In vivo measurement of aromatase inhibition be letrozole (CGS 20267) in post menopausal patients with breast cancer. Clinical Cancer Research. 1:1995;1511-1515.
10. Geisler J., King N., Anker G., Ornati G., Salle E.D., Lønning P.E., Dowsett M. In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. Clinical Cancer Research. 4:1998;2089-2093.
11. Landeghem A.A.J.v., Poortman J., Nabuurs M., Thijssen J.H.H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant breast tissue. Cancer Research. 45:1985;2900-2906.
12. Vermeulen A., Deslypere J.P., Paridaens R., Leclercq G., Roy F., Heuson J.C. Aromatase, 17-beta-hydroxysteroid dehydrogenase and intratissue sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. European Journal of Cancer and Clinical Oncology. 22:1986;515-525.
13. Fishman J., Nisselbaum J.S., Menendez-Botet C.J., Schwartz M.K. Estrone and estradiol content in human breast tumours: relationship to estradiol receptors. Journal of Steroid Biochemistry. 8:1977;893-896.
14. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.-C., Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol, and estrone sulphate and evaluation of sulphatase and aromatase activities in pre- and postmenopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism. 81:1996;1460-1464.
15. Thorsen T., Tangen M., Stoa K.F. Concentration of endogenous oestradiol as related to oestradiol receptor sites in breast tumour cytosol. European Journal of Cancer and Clinical Oncology. 18:1982;333-337.
16. Mistry P., Griffith K., Maynard P.W. Endogenous C19-Steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors. Journal of Steroid Biochemistry. 24:1986;1117-1125.
17. Edery M., Goussard J., Dehennin L., Scholler R., Reiffsteck J., Drosdowsky M.A. Endogenous oestradiol-17-beta concentration in breast tumours determined by mass fragmentography and by mass fragementography and by radioimmunoassay: relationship to receptor content. European Journal of Cancer. 17:1980;115-120.
18. Recchione C., Venturelli E., Manzari A., Cavalleri A., Martinetti A., Secreto G. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues. Journal of Steroid Biochemistry and Molecular Biology. 52:1995;541-546.
19. Millington D.S. Determination of hormonal steroid concentrations in biological extracts by high resolution mass fragmentography. Journal of Steroid Biochemistry. 6:1975;239-245.
20. Thijssen J.H.H., Landeghem A.A.J.v., Poortman J. Uptake and concentration of steroid hormones in mammary tissues. Annals of the New York Academy of Sciences. 464:1986;106-116.
21. Maynard P.V., Brownsey B.G., Griffith K. Oestradiol levels in fractions of human breast tumours. Journal of Endocrinology. 77:1978;P62-P63.
22. Bonney R.C., Reed M.J., Davidson K., Beranek P.A., James V.H.T. The relationship between 17-beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clinical Endocrinology. 19:1983;727-739.
23. Vallent K., Feher T., Bodrogi L., Ribai Z. Steroid-Hormon-Gehalt der Brustsubstanz bei Mammatumouren. Chirurg. 53:1982;34-36.
24. Reed M.J., Aherne G.W., Ghilchik M.W., Patel S., Chakraborty J. Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissue. International Journal of Cancer. 49:1991;562-565.
25. Jong P.C.d., Ven J.v.d., Nortier H.W.R., Maitimu-Smeele I., Donker T.H., Thijssen J.H.H., Slee P.H.T.J., Blankenstein R.A. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole. Cancer Research. 57:1997;2109-2111.
26. Hämäläinen E. A micromethod for the simultaneous determination of clinically important androgens and oestrogens in plasma. Scandinavian Journal of Clinical and Laboratory Investigation. 42:1982;493-498.
27. Lønning P.E., Skulstad P., Sunde A., Thorsen T. Separation of urinary metabolites of radiolabelled estrogens in man by HPLC. Journal of Steroid Biochemistry. 32:1989;91-97.
28. Jacobs S., Lønning P.E., Haynes B., Griggs L., Dowsett M. Measurement of aromatisation by a urine technique suitable for the evaluation of aromatase inhibitors in vivo. Journal of Enzyme Inhibition. 4:1991;315-325.
29. Lønning P.E., Helle S.I., Johannessen D.C., Adlercreutz H., Lien E.A., Tally M., Ekse D., Fotsis T., Anker G.B., Hall K. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. Clinical Endocrinology. 42:1995;23-30.
30. Dowsett M., Goss P.E., Powles T.J., Hutchinson G., Brodie A.M.H., Jeffcoate S.L., Coombes R.C. Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Research. 47:1987;1957-1961.
31. Lønning P.E., Ekse D. A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors. Journal of Steroid Biochemistry and Molecular Biology. 55:1995;409-412.
32. Koch D.D., Peters T. Selection and evaluation of methods. Burtis C.A., Ashwood E.R. Tietz Fundamentals of Clinical Chemistry. 1996;170-181 Saunders, Philadelphia, PA.
33. Landeghem A.A.J.v., Poortman J., Helmond-Agema A., Thijssen J.H.H. Measurement of endogenous sub-cellular concentrations of steroids in tissue. Journal of Steroid Biochemistry. 20:1984;639-644.
34. James V.H.T., McNeill J.M., Beranek P.A., Bonney R.C., Reed M.J. The role of tissue steroids in regulating aromatase and oestradiol 17-beta-hydroxysteroid dehydrogenase activities in breast and endometrial cancer. Journal of Steroid Biochemistry. 25:1986;787-790.